HSBC Holdings
AGIO icon

HSBC Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

HSBC Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,584
Closed -$1M – 3013
2024
Q4 		$1M Buy
30,584
+25,752
+533% +$1.21M ﹤0.01% 1798
2024
Q3 		$220K Sell
4,832
-1,155
-19% -$52.5K ﹤0.01% 2550
2024
Q2 		$261K Sell
5,987
-870
-13% -$31.4K ﹤0.01% 2382
2024
Q1 		$200K Buy
+6,857
New +$184K ﹤0.01% 2681
2022
Q3 		– Sell
-15,424
Closed -$341K – 2899
2022
Q2 		$341K Buy
15,424
+2,333
+18% +$52.7K ﹤0.01% 2562
2022
Q1 		$386K Buy
+13,091
New +$400K ﹤0.01% 2595
2021
Q3 		– Sell
-3,758
Closed -$209K – 2966
2021
Q2 		$209K Sell
3,758
-513
-12% -$28.7K ﹤0.01% 2735
2021
Q1 		$222K Sell
4,271
-1,685
-28% -$83.4K ﹤0.01% 2489
2020
Q4 		$259K Sell
5,956
-422
-7% -$16.7K ﹤0.01% 2664
2020
Q3 		$225K Buy
6,378
+993
+18% +$43.5K ﹤0.01% 2400
2020
Q2 		$288K Buy
+5,385
New +$249K ﹤0.01% 2150
2020
Q1 		– Sell
-7,528
Closed -$363K – 2666
2019
Q4 		$363K Buy
7,528
+457
+6% +$17.3K ﹤0.01% 2414
2019
Q3 		$229K Buy
+7,071
New +$293K ﹤0.01% 2791
2015
Q3 		– Sell
-2,898
Closed -$323K – 1928
2015
Q2 		$323K Buy
+2,898
New +$312K ﹤0.01% 1575
2015
Q1 		– Sell
-1,798
Closed -$201K – 2044
2014
Q4 		$201K Buy
+1,798
New +$161K ﹤0.01% 1700

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HSBC Holdings's AGIO Position: Q1 2025 in Review

HSBC Holdings sold out of Agios Pharmaceuticals (AGIO) in Q1 2025, closing a stake of 30,584 shares — an estimated $1M sold.

HSBC Holdings first reported a position in AGIO in Q4 2014 and held it in 15 quarters. The position peaked at $1M in Q4 2024. 220 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • HSBC Holdings reported no remaining Agios Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • HSBC Holdings sold 30,584 Agios Pharmaceuticals shares in Q1 2025, an estimated $1M.
  • HSBC Holdings first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 15 quarters.
  • HSBC Holdings's Agios Pharmaceuticals position peaked at $1M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.